The Transplantation Society

Nonprofit profile at a glance

EIN
237348742
IRS 990 coverage
2010–2024
Forms available
Form 990 2024
Location
Montreal, Quebec, CA
Phone
5148741717
Rating
76
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Medical Disciplines

Official website

Reported finances

Revenue
$4,888,511
Expenses
$4,504,915
Assets
$13,757,084
Liabilities
$1,276,068

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

32 people listed

Executive titles in this filing

  • DR ELMI MULLER (Immediate Past-President (eff. 9/24))
  • DR JOHN FUNG (President (eff. 9/24))
  • DR MARCELO CANTAROVICH (IMMDIATE PAST PRESIDENT (Ended 9/24))
  • GABRIEL E GONDOLESI (Vice President (eff. 10/24))
  • NADEY HAKIM (President-Elect (eff. 9/24))
  • Stefan Tullius (VICE-PRESIDENT (ENDED 10/24))

Highest reported compensation

  • MARCELLE MCPHADEN (EXECUTIVE DIRECTOR): $131,422 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The transplantation society provides the focus for global leadership in transplantation for the development of the science and clinical practice, scientific communication, continuing education and guidance on the ethical practice.

What it reported doing in 2024

An international forum for the world-wide advancement of organ transplantation including a focus on - development of the science and clinical practice - scientific communication - continuing education - guidance on the ethical practice of transplantation. The organization achieves this focus by making grants to section and regional societies for the purpose of travel, research fellowship, and recognizing individuals who have made outstanding contributions in transplantation. The primary awards and grants are: 1) the medawar prize, named after society co-founder sir peter medawar, is recognized as the world's highest dedicated award for the most outstanding contributions in the field of transplantation. The medawar prize has been awarded to two or more recipients at each of the organization's biennial congresses since 1990. The award is made possible by a generous grant from novartis pharma ag who agreed that a prestigious prize be established and maintained to recognize the outstanding investigators whose contributions have had such a profound influence on the field of organ transplantation. 2) tts thomas starzl innovation award. Named after tom starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the "father of transplantation". The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by dr. Starzl. 3) tts research fellowships are offered for a period of 2 years to support basic and clinical research in the field of transplantation in the laboratory or clinical unit of a full tts member. The fellowships are designed to provide research training for new young investigators with the potential of making a significant contribution to the field of transplantation. 4) travel grants for young investigators and for those with financial difficulties who are members of the organization.

Operating model

Revenue model
Other-operating. 75% of the money available for current operations came from other operating revenue.
Distribution model
Direct operator. The filing allocates 84% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. The filing reports few safeguards for money sent abroad and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 67
  • Transparency & Controls: 78
  • Accountability: 90
  • Sustainability: 64
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 76.4%; rating input score 76
  • Program expense ratio: 74.3%; rating input score 74
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 93.3%; rating input score 93; 17th percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: 1 of 8 controls in place; rating input score 12
    • Claims monitoring procedures: Pass
    • Requires narrative reports: Fail
    • Conducts field audits: Fail
    • May suspend future funding: Fail
    • Requires financial reports: Fail
    • Conducts site visits: Fail
    • Requires grant agreements: Fail
    • May require repayment: Fail
  • Grant itemization coverage: 99.1%; rating input score 99; 37th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 6 of 8 controls in place; rating input score 75
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: Pass
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 7.8%; rating input score 58; 58th percentile among comparable filings
  • Total-asset coverage ratio: 3.05; rating input score 74; 74th percentile among comparable filings
  • Liabilities to assets ratio: 0.09; rating input score 60; 60th percentile among comparable filings
  • Officer compensation ratio: 2.9%; rating input score 69; 69th percentile among comparable filings

Growth

  • Program expense growth: 4.8% per year; rating input score 100; 39th percentile among comparable filings
  • Revenue growth: 3.2% per year; rating input score 100; 28th percentile among comparable filings
  • Asset growth: 3.7% per year; rating input score 100; 28th percentile among comparable filings

Details

  • Where the money goes: 76.4% of revenue deployed · 74.3% of spending went to programs
  • Governance: 21 of 21 board members independent · 6 of 8 filing controls reported
  • Programs: 4 filed program accomplishments · $3.3M in reported program spending
  • Leadership: top reported pay $131K · 32 people listed
  • Highest-paid contractors: 2 contractors listed · $311K reported
  • Consistency: 40 of 41 current checks pass · 1 finding to review
  • Schedules: 6 filed schedules · includes major donors, foreign activity, and grants
  • Filing history: 14 filing years from 2010 to 2024
  • Contacts: How to reach this organization
  • Money network: 6 filed money-flow records
  • Related organizations: 5 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Foreign activity oversight: 7 of 8 not reported.
  • Review — Accountability: Governance controls: 2 of 8 not reported.
  • Review — Sustainability: Operating margin scored 58/100.
  • Review — Transparency & Controls: Domestic grant itemization did not reconcile in the filed values.